Heart, Lung and Circulation
Volume 16, Issue 4 , Pages 243-253, August 2007

What is the Role of Leukocyte Depletion in Cardiac Surgery?

  • Hou-Kiat Lim, MBBS

      Affiliations

    • Cardiac Surgical Research Unit, Alfred Hospital, Melbourne, Australia
    • Monash University Department of Surgery, Alfred Hospital, Melbourne, Australia
  • ,
  • James Anderson, CCP

      Affiliations

    • Cardiac Surgical Research Unit, Alfred Hospital, Melbourne, Australia
    • Department of Perfusion, Alfred Hospital, Melbourne, Australia
  • ,
  • Jee-Yoong Leong, MBBS

      Affiliations

    • Cardiac Surgical Research Unit, Alfred Hospital, Melbourne, Australia
  • ,
  • Salvatore Pepe, PhD

      Affiliations

    • Cardiac Surgical Research Unit, Alfred Hospital, Melbourne, Australia
    • Baker Heart Research Institute (Wynn Domain), Melbourne, Australia
  • ,
  • Robert F. Salamonsen, FJFICM

      Affiliations

    • Department of Intensive Care, Alfred Hospital, Melbourne, Australia
    • Monash University Department of Epidemiology and Preventive Medicine, Melbourne, Australia
  • ,
  • Franklin L. Rosenfeldt, FRACS

      Affiliations

    • Cardiac Surgical Research Unit, Alfred Hospital, Melbourne, Australia
    • Baker Heart Research Institute (Wynn Domain), Melbourne, Australia
    • Monash University Department of Surgery, Alfred Hospital, Melbourne, Australia
    • Monash University Department of Epidemiology and Preventive Medicine, Melbourne, Australia
    • Corresponding Author InformationCorresponding author at: Department of Cardiothoracic Surgery, The Alfred Hospital, Commercial Road, Prahran, Victoria 3181, Australia. Tel.: +61 3 9276 3684; fax: +61 3 9276 2317.

Received 29 June 2006; received in revised form 7 December 2006; accepted 7 January 2007.

Leukocytes play an important pathogenic role in ischaemia-reperfusion injury. During cardiopulmonary bypass, leukocyte filters have the potential to remove leukocytes, thereby reducing contact of activated leukocytes with the endothelium of target organs. Improvement in the safety and efficacy of commercially available leukocyte filters in recent years has led to their increasing use in cardiac surgery. However, the benefits have been inconsistent. Current evidence suggests that leukocyte depletion may not have a significant impact in low risk elective coronary artery bypass grafting but may be beneficial in valve surgery and high-risk cardiac surgery. High-risk surgical groups that may benefit from leukocyte filtration are those with left ventricular hypertrophy (LV mass>300g), poor ejection fraction (EF<40%), chronic obstructive airways disease (predicted FEV1<75%), prolonged ischaemia (cross clamp time>120min or cardiac transplantation), paediatric cardiac surgery and patients in cardiogenic shock requiring emergency coronary artery bypass grafting. Future trials should be powered to detect important clinical end points and be designed to avoid premature exhaustion of the filter.

Abbreviations: AXR, aortic cross-clamp, CABGs, coronary artery bypass grafts, CI, cardiac index, CPB, cardiopulmonary bypass, CRP, C-reactive protein, EF, ejection fraction, FEV1, forced expiratory volume (1s), IABP, intra-aortic balloon pump, ICAM, intercellular adhesion molecule, ICU, intensive care unit, IL, interleukin, LV, left ventricle, LD, leukocyte depletion, LDTC, leukocyte depleted terminal cardioplegia, LF, leukocyte filtration, MPO, myeloperoxidase, MDA, malondialdehyde, OI, oxygenation index (arterial oxygen tension/inspired oxygen fraction), PAP, pulmonary artery pressure, PCWP, pulmonary capillary wedged pressure, PMNE, polymorphonuclear elastase, PRCT, prospective randomised control trial, PVR, pulmonary vascular resistance, TNF-alpha, tumour necrosis factor-alpha, RI, respiratory index, RBC, red blood cell, Trop, troponin, WBC, white blood cell count

Keywords: Cardiopulmonary bypass, Coronary artery bypass graft, Leukocytes, Reperfusion

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1443-9506(07)00028-5

doi:10.1016/j.hlc.2007.01.003

Heart, Lung and Circulation
Volume 16, Issue 4 , Pages 243-253, August 2007